The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Area of Science:

• Oncology
• Genomics
• Pharmacology

Background:

• Translating cancer genomic data into therapeutic strategies is challenging.
• Preclinical models with genomic diversity and detailed annotation are crucial for cancer research.
• The Cancer Cell Line Encyclopedia (CCLE) addresses this need by compiling extensive cancer cell line data.

Purpose of the Study:

• To describe the Cancer Cell Line Encyclopedia (CCLE) resource.
• To identify genetic, lineage, and gene-expression-based predictors of anticancer drug sensitivity.
• To demonstrate the utility of large, annotated cell-line collections for preclinical drug stratification.

Main Methods:

• Compiled gene expression, copy number, and sequencing data for 947 human cancer cell lines.
• Acquired pharmacological profiles for 24 anticancer drugs across 479 cell lines.
• Analyzed data to identify predictors of drug sensitivity.

Main Results:

• Identified novel correlations between cell lineage and drug sensitivity (e.g., plasma cell lineage with IGF1 receptor inhibitors).
• Found AHR expression predicts MEK inhibitor efficacy in NRAS-mutant lines.
• Demonstrated SLFN11 expression predicts sensitivity to topoisomerase inhibitors.

Conclusions:

• Large, annotated cell-line collections like CCLE can facilitate preclinical stratification of anticancer agents.
• Genetic predictions of drug response can be integrated into clinical trial design for personalized medicine.
• CCLE advances the understanding of tumor biology and therapeutic possibilities.